We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+5.66%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$2.42B
AUM Growth
+$196M
Cap. Flow
+$80.1M
Cap. Flow %
3.32%
Top 10 Hldgs %
62.67%
Holding
327
New
19
Increased
94
Reduced
151
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 5.04%
2 Financials 2.8%
3 Communication Services 1.35%
4 Healthcare 1.04%
5 Consumer Discretionary 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
326
Mondelez International
MDLZ
$82.9B
-2,821
Closed -$204K
RIO icon
327
Rio Tinto
RIO
$152B
-2,897
Closed -$216K

Similar funds

Aspiriant LLC's Q1 2024 Portfolio in Review

As of Q1 2024, Aspiriant LLC held 327 positions worth $2.42B, up 8.8% from $2.22B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Aspiriant LLC deployed $80.1M of net new capital in Q1 2024, opening 19 new positions and adding to 94 existing holdings. Its largest new stake was Simon Property Group: 7,281 shares worth $1.14M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, down from 5.7% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $24.5M trimmed.

  • Aspiriant LLC's largest Q1 2024 buy was Simon Property Group: 7,281 shares worth $1.14M.
  • Aspiriant LLC added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $102M increase.
  • Aspiriant LLC's biggest Q1 2024 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $24.5M.
  • Aspiriant LLC fully exited ChargePoint in Q1 2024, selling an estimated $1.17M.
  • Aspiriant LLC's ten largest holdings make up 63% of its $2.42B portfolio in Q1 2024.
  • Aspiriant LLC opened 19 new positions and closed 10 in Q1 2024.
  • Aspiriant LLC's portfolio value rose 8.8% quarter-over-quarter to $2.42B.

Based on Aspiriant LLC's 13F filing for Q1 2024, filed 15 Apr 2024.